$14 Million Gift to Transform UC Neuroscience Institute
CINCINNATIThe James J. and Joan A. Gardner Family Foundation has committed $14 million to the UC Neuroscience Institute that will help fund a new, state-of-the-art facility to enhance treatment and research efforts for chronic and progressive neurologic conditions and disorders like Parkinsons disease.
The contribution is the second major gift to the UC Neuroscience Institute from the Gardner Family Foundation, and its announcement comes at the institute's 15th anniversary.
"Im proud of the collaboration happening at the UC Neuroscience Institute and excited about what this gift means for the future of neurologic care and research in and beyond Cincinnati, said University of Cincinnati President Santa J. Ono. "This gift will create a new home for UC Neuroscience Institute that will allow our medical students, faculty and staff to learn and teach in a cutting-edge environment. The Gardner familys investment in UC is incredible, and I am deeply grateful for their generosity.
UC Neuroscience Institute is a collaboration between UCs College of Medicine and UC Health. Its new building, at a yet-to-be-determined central location, will be designed to foster a streamlined patient-centered experience, collaboration among clinicians and researchers and educational activities for neuroscience faculty, staff, patients and family members.
"The new headquarters will transform the patient experience beyond measure, said Richard Lofgren, MD, MPH, president and CEO of UC Health. "UC Neuroscience Institute is already a preeminent provider of patient care for neurologic disorders and mental conditions and a leader in neuroscience research. This gift will further elevate its efforts and improve the outlook for the millions affected by neurological disorders.
Over the past five years, the institute has grown both in size and revenue. This year alone, it added 16 new physicians, and donors contributed more than $16 million in FY14 (July 1, 2013, through June 30, 2014.)
"The generosity of the Gardner Family Foundation will help us recruit and retain the best specialists and researchers and create patient resources not available in other hospital systems, said Joe Broderick, MD, director of the UC Neuroscience Institute. "Our new home will speak to our goal of being a community partner committed to raising the level of patient care, research and education in the region.
In 2007, the Gardner Family Foundation gave $5.5 million to create the James J. and Joan A. Gardner Family Center for Parkinsons Disease and Movement Disorders, one of 11 centers of excellence at UC Neuroscience Institute.
The gift was inspired by James Gardners wife, Joan, who suffers from Parkinsons disease. The gift has since allowed the center to optimize the patient experience by creating a patient-centered culture.
"The Gardner family embodies what it means to pay it forward, said Rodney Grabowski, UC Foundation president. "I am thankful for their philanthropic support at UC Neuroscience Institute , which is sure to set a precedent that inspires others to give as well. Their generosity will positively impact lives for years to come.
UC Neuroscience Institute was founded in 1998 by a handful of doctors who wanted to foster collaboration among physicians in order to provide better patient care. Since its inception, more than 25,000 donors, from community members to esteemed faculty and physicians, have contributed more than $60 million in support. Today, UC Neuroscience Institute is the largest and best recognized provider of advanced specialty neuroscience care in the Greater Cincinnati region and its research efforts are nationally acclaimed.
Joseph Broderick, MD
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.